| 摘要 |
FIELD: medicine. ^ SUBSTANCE: there is disclosed application of compound antagonist VEGF representing VEGFR1R2-FcöCl(a) or Flt1D2. Flk1D3. FcöCl (a) and antiproliferative agent: paclitaxel, docetaxel, or cisplatin, carboplatin, iproplatin for making a medical product for cancer treatment and/or tumour growth reduction or inhibition in an indigent person (versions), relevant method, pharmaceutical composition and a kit for cancer treatment. ^ EFFECT: overtotal effect of the disclosed combination (97% tumour suppression) observed without any by-effects. ^ 10 cl, 2 dwg, 1 tbl |
